Market Tracker

09/30 6:05pm ET

Novavax Inc (NASDAQ:NVAX)

4.17
Data as of Sep 30
 -0.15 / -3.47%
Today’s Change
2.68
Today|||52-Week Range
6.95
-18.55%
Year-to-Date

Today’s Trading

Previous close4.32
Today’s open4.31
Day’s range4.16 - 4.35
Volume3,915,461
Average volume (3 months)2,953,647
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)+6.41%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book4.44

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...-1.23-3.55%
BLUEbluebird bio Inc-1.02-2.76%
IMGNImmunoGen Inc-0.58-5.19%
KITEKite Pharma Inc-0.34-1.18%
Data as of 4:00pm ET, 09/30/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts